BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7026138)

  • 21. [Prokinetic drugs in digestive disorders].
    Carella G; Marra L
    Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metoclopramide in the treatment of an infant with gastroesophageal hypomotility.
    Ponte CD
    Drug Intell Clin Pharm; 1982 Dec; 16(12):965-6. PubMed ID: 7151706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The premedicant and anti-emetic action of metoclopramide.
    Dundee JW; Clarke RS
    Postgrad Med J; 1973 Jul; 49 Suppl 4():suppl 4:34-8. PubMed ID: 4804465
    [No Abstract]   [Full Text] [Related]  

  • 24. Reducing the incidence of postoperative nausea and vomiting.
    Broomhead CJ
    Br J Hosp Med; 1995 May 17-Jun 6; 53(10):511-2. PubMed ID: 7640810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GI drugs: histamine antagonists, sucralfate and metoclopramide.
    Karb VB
    J Neurosci Nurs; 1988 Jun; 20(3):201-2. PubMed ID: 2968422
    [No Abstract]   [Full Text] [Related]  

  • 26. [Benalgesic in the treatment of spastic dyskinesias of the digestive system in infants and children. Clinico-pharmacological considerations].
    Brunelli G
    Minerva Pediatr; 1967 Oct; 19(43):1932-5. PubMed ID: 4387845
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Madisch A; Vinson BR; Abdel-Aziz H; Kelber O; Nieber K; Kraft K; Storr M
    Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metoclopramide: extrapyramidal symptoms in children.
    Prescrire Int; 2007 Oct; 16(91):201. PubMed ID: 17926838
    [No Abstract]   [Full Text] [Related]  

  • 29. Metoclopramide.
    Nurs Times; 2005 Mar 22-28; 101(12):37. PubMed ID: 15822709
    [No Abstract]   [Full Text] [Related]  

  • 30. [An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
    Tsukagoshi S; Ohta J; Taguchi T
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2276-81. PubMed ID: 8259839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastronerton (metoclopramide) in gastrointestinal diseases. Clinical effect and tolerance].
    Conti F; Testaguzza F
    Fortschr Med; 1980 May; 98(19):753-6. PubMed ID: 7399389
    [No Abstract]   [Full Text] [Related]  

  • 32. Metoclopramide hydrochloride: a gastrointestinal stimulant with multiple uses.
    Romankiewicz N
    J Pract Nurs; 1983 Mar; 33(3):12-3. PubMed ID: 6550634
    [No Abstract]   [Full Text] [Related]  

  • 33. Flatulent dyspepsia.
    Johnson AG
    Postgrad Med J; 1973 Jul; 49 Suppl 4():suppl 4:104-7. PubMed ID: 4614242
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose metoclopramide in cancer chemotherapy-induced nausea and vomiting.
    Bui NB; Marit G; Hoerni B
    Cancer Treat Rep; 1982 Dec; 66(12):2107-8. PubMed ID: 7139655
    [No Abstract]   [Full Text] [Related]  

  • 35. Metoclopramide. An updated review of its pharmacological properties and clinical use.
    Harrington RA; Hamilton CW; Brogden RN; Linkewich JA; Romankiewicz JA; Heel RC
    Drugs; 1983 May; 25(5):451-94. PubMed ID: 6345129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent generalized anxiety after brief exposure to the dopamine antagonist metoclopramide.
    Kluge M; Schüssler P; Steiger A
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):193-5. PubMed ID: 17362439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attempt to evaluate the indications of metoclopramide in gastroenterology (author's transl)].
    Koçián J; Kociánová J
    Cesk Gastroenterol Vyz; 1975 Jul; 29(5):335-40. PubMed ID: 1098784
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gastrointestinal motility disorders. Effective phytotherapy alternatives to MCP (metoclopramide)].
    MMW Fortschr Med; 2014 Nov; 156(19):80-1. PubMed ID: 25510031
    [No Abstract]   [Full Text] [Related]  

  • 39. Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study.
    Cham S; Basire M; Kelly AM
    Emerg Med Australas; 2004 Jun; 16(3):208-11. PubMed ID: 15228463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of functional gastroduodenal evacuation disorders with metoclopramide (Paspertin)].
    Schütz E
    Munch Med Wochenschr; 1967 Jun; 109(22):1227-31. PubMed ID: 5631741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.